SCHEMBL23302367

SCHEMBL23302367

CNc1cc(C(F)(F)F)cc(Cl)c1[N+](=O)[O-]

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ MAPT P10636 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ MAPK1 P28482 3/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ OPRD1 P41143 1/20 0.48
▸ OPRK1 P41145 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ TLR9 Q9NR96 1/20 0.48
▸ GPR55 Q9Y2T6 1/20 0.48
▸ TSHR P16473 4/20 0.47
▸ CYP3A4 P08684 3/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29896834 1.00 ALDH1A1 (0.48) ALDH1A1MEN1MAPTKMT2AMAPK1
SCHEMBL16174996 0.83 TSHR (0.60) ALDH1A1MEN1MAPTKMT2AMAPK1
SCHEMBL31346023 0.80 TDP1 (0.53) ALDH1A1MEN1MAPTKMT2AMAPK1
SCHEMBL30039907 0.79 ALDH1A1 (0.40) ALDH1A1MEN1MAPTKMT2AMAPK1
SCHEMBL9771642 0.78 ALDH1A1 (0.64) ALDH1A1MEN1MAPTKMT2AMAPK1
SCHEMBL30038982 0.78 ALDH1A1 (0.64) ALDH1A1MEN1MAPTKMT2AMAPK1
SCHEMBL30038957 0.77 ALDH1A1 (0.53) ALDH1A1MEN1MAPTKMT2AMAPK1
SCHEMBL22154442 0.77 ALDH1A1 (0.53) ALDH1A1MEN1MAPTKMT2AMAPK1
SCHEMBL30038307 0.77 TSHR (0.53) ALDH1A1MEN1MAPTKMT2AMAPK1
SCHEMBL2792876 0.77 TSHR (0.53) ALDH1A1MEN1MAPTKMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240262842-A1 SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT MERCK SHARP & DOHME LLC 2024-08-08 — — US disclosed
US-20240246968-A1 SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT MERCK SHARP & DOHME LLC 2024-07-25 — — US disclosed
EP-4329749-A1 SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT Merck Sharp & Dohme LLC (US) 2024-03-06 — — EP disclosed
EP-4329750-A1 SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT Merck Sharp & Dohme LLC (US) 2024-03-06 — — EP disclosed
US-20230023023-A1 4-AMINOBUT-2-ENAMIDE DERIVATIVES AND SALTS THEREOF ASTEX THERAPEUTICS LIMITED (GB) 2023-01-26 — — US disclosed
WO-2022232320-A1 SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT MERCK SHARP & DOHME CORP. (US) 2022-11-03 — — WO disclosed
WO-2021084765-A1 4-AMINOBUT-2-ENAMIDE DERIVATIVES AND SALTS THEREOF TAIHO PHARMACEUTICAL CO., LTD (JP) 2021-05-06 — — WO disclosed
WO-2021085653-A1 4-AMINOBUT-2-ENAMIDE DERIVATIVES AND SALTS THEREOF TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230023023-A1 4-AMINOBUT-2-ENAMIDE DERIVATIVES AND SALTS THEREOF KRAS, NRAS, HRAS ALDH1A1 2807/4885MEN1 2108/4885MAPT 3117/4885
US-20240246968-A1 SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT KRAS, NRAS, HRAS ALDH1A1 3065/4885MEN1 498/4885MAPT 4652/4885
US-20240262842-A1 SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT KRAS, NRAS, HRAS ALDH1A1 1875/4885MEN1 237/4885MAPT 4668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback